Coeptis Therapeutics Inc (COEP) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $12.23
• Market Cap: $68.21M
• EPS: $-6.87
• 52-Week High: $21.41
• 52-Week Low: $6.26

Market Sentiment

Coeptis Therapeutics Inc currently has a Bullish sentiment score of 0.23.

About Coeptis Therapeutics Inc

Coeptis Therapeutics Inc. is a biopharmaceutical company based in Wexford, Pennsylvania, dedicated to developing and commercializing innovative cancer therapies that combine brand-name and generic pharmaceuticals with advanced cell therapy platforms. By focusing on addressing unmet medical needs in oncology, Coeptis seeks to improve treatment outcomes and enhance the quality of life for cancer patients. With a robust commitment to research and development, the company is strategically positio...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Coeptis Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does COEP pay dividends?

Coeptis Therapeutics Inc (COEP) does not currently pay a regular dividend.

What is COEP's market cap?

Coeptis Therapeutics Inc (COEP) has a market capitalization of $68.21M with a current stock price of $12.23.